Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic mitral regurgitation.

J S Rankin1, M S Hickey, L R Smith

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710.

Circulation
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using observational data to estimate prognosis: an example using a coronary artery disease registry.

Statistics in medicine·2001
Same author

Statistics for the rest of us.

The Journal of thoracic and cardiovascular surgery·2001
Same author

Insufficiency of the native aortic valve and left ventricular assist system inflow valve after support with an implantable left ventricular assist system: signs, symptoms, and concerns.

The Journal of thoracic and cardiovascular surgery·2001
Same author

Publications of The American Association for Thoracic Surgery, or "How to be all things to...".

The Journal of thoracic and cardiovascular surgery·2001
Same author

How to get your paper published.

The Journal of thoracic and cardiovascular surgery·2001
Same author

Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000.

The Annals of thoracic surgery·2001
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
See all related articles

Improving outcomes for patients with ischemic mitral regurgitation, a high-risk cardiac surgery group, may involve broader use of mitral valve reconstruction and other targeted therapies.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Mitral Valve Disease

Background:

  • Hospital mortality for adult cardiac operations is decreasing.
  • Ischemic mitral regurgitation (IMR) patients remain at high risk.
  • Current treatment strategies for IMR require optimization.

Purpose of the Study:

  • To identify strategies for improving outcomes in the IMR patient subset.
  • To evaluate the potential benefits of mitral valve reconstruction in IMR.
  • To explore adjunctive therapies for high-risk cardiac surgery patients.

Main Methods:

  • Analysis of existing data on adult cardiac operations and IMR outcomes.
  • Review of current therapeutic measures for acute papillary muscle dysfunction.

Related Experiment Videos

  • Assessment of patient selection criteria for surgical intervention.

    • Main Results:

    • Mitral valve reconstruction may benefit a broader IMR population.
    • Reperfusion therapy shows promise for acute papillary muscle dysfunction.
    • Improved patient selection and earlier surgical consideration for stable patients are suggested.

    Conclusions:

    • Wider application of mitral valve reconstruction could improve IMR outcomes.
    • Integrating reperfusion therapy and refined patient selection enhances prognosis.
    • These strategies may significantly improve the outlook for this challenging subgroup.